| Karl Malone Rogers, MD | |
|
2004 Hayes St, Suite 720, Nashville, TN 37203-2646 | |
| (615) 284-2310 | |
| (615) 284-2385 |
| Full Name | Karl Malone Rogers |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 37 Years |
| Location | 2004 Hayes St, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538112495 | NPI | - | NPPES |
| 900002522 | Other | TN | RAILROAD MEDICARE # |
| 3048819 | Medicaid | TN | |
| 3113880 | Other | TN | BCBS OF TN IND PROVIDER # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD18887 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Thomas West Hospital | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Verdi Oncology Tennessee Pc | 9436571999 | 11 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
Gov. Andrew Cuomo's effort to overhaul New York state's $6 billion home health-care industry is coming under scrutiny from patient advocates and other industry players who say the administration is bowing to the interests of large, politically connected providers.
In this Kaiser Health News column, Louis Saccoccio, executive director of the National Health Care Anti-Fraud Association, makes a case for including health plans' investments in fraud-fighting activities in the medical loss ratio definition. "While the federal government is investing heavily in anti-fraud efforts, private insurers should be given the incentive to do the same. Only through a cooperative and concentrated effort to root out health care fraud can we effectively protect Americans' quality of health care" (Kaiser Health News).
ChromoCure, Inc. (PINKSHEETS: KKUR) is pleased to announce the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell, along with an independent commentary on the discovery, end a major controversy in the field of cancer research as to whether aneuploidy is a cause or a consequence of cancer and further proves the aneuploidy basis of cancer.
By studying the aging of memory in the mouse, researchers in the Laboratoire Neurobiologie des Processus Adaptatifs have developed an experimental protocol that can detect age-related memory deficits at an early stage. They have shown that even at 10 months, which corresponds to a third of their life expectancy, some mice present with age-related memory disorders.
› Verified 6 days ago
| Entity Name | Verdi Oncology Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336779974 PECOS PAC ID: 9436571999 Enrollment ID: O20200630000628 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
Gov. Andrew Cuomo's effort to overhaul New York state's $6 billion home health-care industry is coming under scrutiny from patient advocates and other industry players who say the administration is bowing to the interests of large, politically connected providers.
In this Kaiser Health News column, Louis Saccoccio, executive director of the National Health Care Anti-Fraud Association, makes a case for including health plans' investments in fraud-fighting activities in the medical loss ratio definition. "While the federal government is investing heavily in anti-fraud efforts, private insurers should be given the incentive to do the same. Only through a cooperative and concentrated effort to root out health care fraud can we effectively protect Americans' quality of health care" (Kaiser Health News).
ChromoCure, Inc. (PINKSHEETS: KKUR) is pleased to announce the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell, along with an independent commentary on the discovery, end a major controversy in the field of cancer research as to whether aneuploidy is a cause or a consequence of cancer and further proves the aneuploidy basis of cancer.
By studying the aging of memory in the mouse, researchers in the Laboratoire Neurobiologie des Processus Adaptatifs have developed an experimental protocol that can detect age-related memory deficits at an early stage. They have shown that even at 10 months, which corresponds to a third of their life expectancy, some mice present with age-related memory disorders.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karl Malone Rogers, MD 2004 Hayes St, Suite 720, Nashville, TN 37203-2646 Ph: (615) 284-2310 | Karl Malone Rogers, MD 2004 Hayes St, Suite 720, Nashville, TN 37203-2646 Ph: (615) 284-2310 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
Gov. Andrew Cuomo's effort to overhaul New York state's $6 billion home health-care industry is coming under scrutiny from patient advocates and other industry players who say the administration is bowing to the interests of large, politically connected providers.
In this Kaiser Health News column, Louis Saccoccio, executive director of the National Health Care Anti-Fraud Association, makes a case for including health plans' investments in fraud-fighting activities in the medical loss ratio definition. "While the federal government is investing heavily in anti-fraud efforts, private insurers should be given the incentive to do the same. Only through a cooperative and concentrated effort to root out health care fraud can we effectively protect Americans' quality of health care" (Kaiser Health News).
ChromoCure, Inc. (PINKSHEETS: KKUR) is pleased to announce the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell, along with an independent commentary on the discovery, end a major controversy in the field of cancer research as to whether aneuploidy is a cause or a consequence of cancer and further proves the aneuploidy basis of cancer.
By studying the aging of memory in the mouse, researchers in the Laboratoire Neurobiologie des Processus Adaptatifs have developed an experimental protocol that can detect age-related memory deficits at an early stage. They have shown that even at 10 months, which corresponds to a third of their life expectancy, some mice present with age-related memory disorders.
› Verified 6 days ago
Megan Desai, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |